BRAF and MEK Inhibitor–Induced Cardiotoxicity in Metastatic Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Acta Oncologica (Stockholm, Sweden)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting
Acta Oncol 2021 Oct 19;[EPub Ahead of Print], S Pedersen, KO Larsen, AH Christensen, IM Svane, B Zerahn, E EllebaekFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.